Neurosarkoidose

Peter Brøgger Christensen; Yousef Yavarian; Ida Holm; Ismael Barzinji; Claudia Christina Hilt Kristensen

Neurosarkoidose

Peter Brøgger Christensen, Yousef Yavarian, Ida Holm, Ismael Barzinji, Claudia Christina Hilt Kristensen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

39 Downloads (Pure)

Abstract

Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.

Bidragets oversatte titel	Neurosarcoidosis
Originalsprog	Dansk
Artikelnummer	V09210704
Tidsskrift	Ugeskrift for laeger
Vol/bind	184
Udgave nummer	17
Sider (fra-til)	1604-1607
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 5 sep. 2022

Emneord

Central Nervous System Diseases/diagnostic imaging
Diagnosis, Differential
Humans
Prognosis
Sarcoidosis/diagnosis

Adgang til dokumentet

Christensen et al. (2022). NeurosarkoidoseForlagets udgivne version, 815 KBLicens: CC BY-NC-ND 4.0

https://ugeskriftet.dk/videnskab/neurosarkoidoseLicens: CC BY-NC-ND 4.0

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Andre filer og links

http://www.scopus.com/inward/record.url?scp=85137648761&partnerID=8YFLogxK

Citationsformater

@article{389aef46406b47988b6d98ef635ee179,

title = "Neurosarkoidose",

abstract = "Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.",

keywords = "Central Nervous System Diseases/diagnostic imaging, Diagnosis, Differential, Humans, Prognosis, Sarcoidosis/diagnosis",

author = "Christensen, {Peter Br{\o}gger} and Yousef Yavarian and Ida Holm and Ismael Barzinji and Kristensen, {Claudia Christina Hilt}",

year = "2022",

month = sep,

day = "5",

language = "Dansk",

volume = "184",

pages = "1604--1607",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "17",

}

TY - JOUR

T1 - Neurosarkoidose

AU - Christensen, Peter Brøgger

AU - Yavarian, Yousef

AU - Holm, Ida

AU - Barzinji, Ismael

AU - Kristensen, Claudia Christina Hilt

PY - 2022/9/5

Y1 - 2022/9/5

N2 - Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.

AB - Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.

KW - Central Nervous System Diseases/diagnostic imaging

KW - Diagnosis, Differential

KW - Humans

KW - Prognosis

KW - Sarcoidosis/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85137648761&partnerID=8YFLogxK

M3 - Tidsskriftartikel

C2 - 35179115

SN - 0041-5782

VL - 184

SP - 1604

EP - 1607

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 17

M1 - V09210704

ER -

Neurosarkoidose

Abstract

Emneord

Adgang til dokumentet

AUB Link

Andre filer og links

Fingeraftryk

Citationsformater